Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Life Sciences|January 1, 1996
U-19451A: a selective inducible nitric oxide synthase inhibitorN C Stratman, G J Fici, V H SethyAmino Acids|January 1, 1999
Pharmacological approaches to counter the toxicity of DopaP F VonVoigtlander, G J Fici, J S AlthausExperimental Cell Research|April 1, 1989
Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factorP D Bonin, G J Fici, J P SinghResearch Communications in Molecular Pathology and Pharmacology|March 1, 1995
Antibody transformation by peroxynitrite as determined using capillary electrophoresis: a feasibility studyJ S Althaus, G J Fici, P F VonVoigtlanderFree Radical Biology & Medicine|January 1, 1997
Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicityG J Fici, J S Althaus, P F VonVoigtlanderLife Sciences|January 1, 1997
D1 dopamine receptor activity of anti-parkinsonian drugsG J Fici, H Wu, P F VonVoigtlander, et al.Brain Research|September 9, 1996
D2 and D1 dopaminergic activity of 7-OH-DPATV H Sethy, B R Ellerbrock, G J Fici, et al.Research Communications in Molecular Pathology and Pharmacology|March 1, 1996
Protective effects of tirilazad mesylate in a cellular model of peroxynitrite toxicityG J Fici, J S Althaus, E D Hall, et al.Journal of Veterinary Pharmacology and Therapeutics|February 6, 2014
Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergyA J Gonzales, J W Bowman, G J Fici, et al.Nature|July 5, 1990
Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 geneL A Erickson, G J Fici, J E Lund, et al.Pageof 2